Rapid and Extraction-Free Detection of SARS-CoV-2 from Saliva by Colorimetric Reverse-Transcription Loop-Mediated Isothermal Amplification. (24th October 2020)
- Record Type:
- Journal Article
- Title:
- Rapid and Extraction-Free Detection of SARS-CoV-2 from Saliva by Colorimetric Reverse-Transcription Loop-Mediated Isothermal Amplification. (24th October 2020)
- Main Title:
- Rapid and Extraction-Free Detection of SARS-CoV-2 from Saliva by Colorimetric Reverse-Transcription Loop-Mediated Isothermal Amplification
- Authors:
- Lalli, Matthew A
Langmade, Joshua S
Chen, Xuhua
Fronick, Catrina C
Sawyer, Christopher S
Burcea, Lauren C
Wilkinson, Michael N
Fulton, Robert S
Heinz, Michael
Buchser, William J
Head, Richard D
Mitra, Robi D
Milbrandt, Jeffrey - Abstract:
- Abstract: Background: Rapid, reliable, and widespread testing is required to curtail the ongoing COVID-19 pandemic. Current gold-standard nucleic acid tests are hampered by supply shortages in critical reagents including nasal swabs, RNA extraction kits, personal protective equipment, instrumentation, and labor. Methods: To overcome these challenges, we developed a rapid colorimetric assay using reverse-transcription loop-mediated isothermal amplification (RT-LAMP) optimized on human saliva samples without an RNA purification step. We describe the optimization of saliva pretreatment protocols to enable analytically sensitive viral detection by RT-LAMP. We optimized the RT-LAMP reaction conditions and implemented high-throughput unbiased methods for assay interpretation. We tested whether saliva pretreatment could also enable viral detection by conventional reverse-transcription quantitative polymerase chain reaction (RT-qPCR). Finally, we validated these assays on clinical samples. Results: The optimized saliva pretreatment protocol enabled analytically sensitive extraction-free detection of SARS-CoV-2 from saliva by colorimetric RT-LAMP or RT-qPCR. In simulated samples, the optimized RT-LAMP assay had a limit of detection of 59 (95% confidence interval: 44–104) particle copies per reaction. We highlighted the flexibility of LAMP assay implementation using 3 readouts: naked-eye colorimetry, spectrophotometry, and real-time fluorescence. In a set of 30 clinical salivaAbstract: Background: Rapid, reliable, and widespread testing is required to curtail the ongoing COVID-19 pandemic. Current gold-standard nucleic acid tests are hampered by supply shortages in critical reagents including nasal swabs, RNA extraction kits, personal protective equipment, instrumentation, and labor. Methods: To overcome these challenges, we developed a rapid colorimetric assay using reverse-transcription loop-mediated isothermal amplification (RT-LAMP) optimized on human saliva samples without an RNA purification step. We describe the optimization of saliva pretreatment protocols to enable analytically sensitive viral detection by RT-LAMP. We optimized the RT-LAMP reaction conditions and implemented high-throughput unbiased methods for assay interpretation. We tested whether saliva pretreatment could also enable viral detection by conventional reverse-transcription quantitative polymerase chain reaction (RT-qPCR). Finally, we validated these assays on clinical samples. Results: The optimized saliva pretreatment protocol enabled analytically sensitive extraction-free detection of SARS-CoV-2 from saliva by colorimetric RT-LAMP or RT-qPCR. In simulated samples, the optimized RT-LAMP assay had a limit of detection of 59 (95% confidence interval: 44–104) particle copies per reaction. We highlighted the flexibility of LAMP assay implementation using 3 readouts: naked-eye colorimetry, spectrophotometry, and real-time fluorescence. In a set of 30 clinical saliva samples, colorimetric RT-LAMP and RT-qPCR assays performed directly on pretreated saliva samples without RNA extraction had accuracies greater than 90%. Conclusions: Rapid and extraction-free detection of SARS-CoV-2 from saliva by colorimetric RT-LAMP is a simple, sensitive, and cost-effective approach with broad potential to expand diagnostic testing for the virus causing COVID-19. … (more)
- Is Part Of:
- Clinical chemistry. Volume 67:Number 2(2021)
- Journal:
- Clinical chemistry
- Issue:
- Volume 67:Number 2(2021)
- Issue Display:
- Volume 67, Issue 2 (2021)
- Year:
- 2021
- Volume:
- 67
- Issue:
- 2
- Issue Sort Value:
- 2021-0067-0002-0000
- Page Start:
- 415
- Page End:
- 424
- Publication Date:
- 2020-10-24
- Subjects:
- SARS-CoV-2 -- COVID-19 -- acute respiratory syndrome -- LAMP -- RT-LAMP -- saliva -- rapid diagnosis -- point-of-care testing -- high-throughput testing -- cost-effective -- preventive medicine
Clinical chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
Biochimie -- Périodiques
Diagnostics biologiques -- Périodiques
Biochemistry
Clinical chemistry
Pharmaceutical chemistry
Biochemistry
Laboratory Techniques and Procedures
Klinische chemie
Periodicals
616.075605 - Journal URLs:
- http://www.oxfordjournals.org/ ↗
https://academic.oup.com/clinchem ↗
http://catalog.hathitrust.org/api/volumes/oclc/1554929.html ↗
http://www.clinchem.org/ ↗ - DOI:
- 10.1093/clinchem/hvaa267 ↗
- Languages:
- English
- ISSNs:
- 0009-9147
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21710.xml